Table 4 Mean age, mean follow-up, and clinical outcomes using various prostheses
Prosthesis | Mean age | Mean follow-up (years) | Survival rate (%) | Mean ROM (°) | Mean KSKS (points) | Mean KSFS (points) | Reference |
|---|---|---|---|---|---|---|---|
Trekking CR (fixed) | 68.8 | 10 | 95.7 | 101.2 | 86.4 | 84.4 | Serna et al. [28] |
Trekking PS (fixed) | 70.1 | 10 | 92.7 | 100.7 | 85.2 | 85.6 | Serna et al. [28] |
Duracon (fixed) | 63 | 11 | 95.6 | 115 | 84 | 73 | Jauregui et al. [29] |
NexGen LPS-Flex (mobile) | 61.5 | 11.2 | 99.5 | 131 | 92 | 80 | Kim et al. [30] |
PFC Sigma PS (mobile) | 73 | 11.5 | 96.6 | 106 | 70.1 | 58 | Ulivi et al. [31] |
Scorpio PS (fixed) | 68 | 8 | 97.7 | 129 | 97 | 75 | Chang et al. [32] |
AGC PS (fixed) | 69.6 | 8.7 | 98.7 | 115 | 85 | 77 | Faris et al. [33] |
Genesis I (CR or PS fixed) | 69.3 | 11 | 90.1 | - | KSS 81 | - | Victor et al. [34] |
Genesis II (CR or PS fixed) | 66 | 11 | 98.1 | - | KSS 83 | - | Victor et al. [34] |
MPK. Alumina (fixed) | 72 | 10 | 99.1 | 116 | 89 | 68 | Nakamura et al. [35] |
NexGen LPS (fixed) | 65.3 | 15.6 | 98.7 | 128 | KSS 93 | - | Kim et al. [36] |
NexGen LPS-Flex (fixed) | 65.3 | 15.6 | 98.4 | 127 | KSS 92 | - | Kim et al. [36] |
MIS NexGen CR-Flex (fixed) | 67.4 | 10.3 | 94.7 | 124 | 91 | 74 | The current study |